Leadership

Executive Leadership Team

Ignite Proteomics is led by an executive team with deep experience in oncology commercialization, public-company finance, and building and scaling healthcare platforms through growth and public listing.

  • Portrait of Jeffrey Busch, Chief Executive Officer & Chairman of Ignite Proteomics

    Jeffrey Busch

    Chief Executive Officer & Chairman

    Public-company CEO and healthcare entrepreneur with 30+ years of experience building, financing and scaling healthcare, biotechnology and real estate platforms.

    Founder and former Chairman & CEO of Global Medical REIT, which he built from inception into a NYSE-listed healthcare real estate company with more than $1.5B of enterprise value and over $1B of capital raised.

    LinkedIn profile — pending

  • Portrait of Faith Zaslavsky, President of Ignite Proteomics

    Faith Zaslavsky

    President

    Oncology commercialization leader with 25+ years of experience across sales, marketing, medical affairs, strategic accounts, payer access and physician adoption.

    Former President of Oncology / General Manager at Myriad Genetics, where she led a multi-product oncology portfolio generating approximately $150MM of annual revenue. Former President and CEO of Theralink Technologies.

    LinkedIn profile — pending

  • Portrait of Ronald Tam, Vice Chairman of Ignite Proteomics

    Ronald Tam

    Vice Chairman

    Senior finance and capital markets executive with 25+ years of experience in corporate finance, M&A, capital raising and public-company execution.

    Former CFO of XtalPi Holdings, a Hong Kong-listed AI-enabled drug discovery platform. Previously held senior roles at Jefferies, UBS, BOCI, ING Barings, HSBC and Ernst & Young.

    LinkedIn profile — pending